Skip to main content
NRC
NASDAQ Industrial Applications And Services

Founder-Related Trusts Sell $5M in NRC Health Stock; Chairman's Direct Stake Drops Below 5%

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$18.79
Mkt Cap
$423.465M
52W Low
$11.014
52W High
$22.79
Market data snapshot near publication time

Summary

Trusts linked to NRC Health's founder and Chairman sold over $5 million in stock, further reducing insider ownership and confirming a trend of stake reduction.


Key Events

  • Significant Insider Sales

    Trusts related to founder and Chairman Michael D. Hays sold 250,000 shares on June 10, 2026, for a total of approximately $5.03 million at weighted average prices between $20.02 and $21.05 per share.

  • Chairman's Reduced Stake

    Michael D. Hays' direct beneficial ownership (excluding disclaimed shares) fell below 5% as of March 23, 2026, indicating a continued reduction in his personal stake.

  • Updated Ownership Structure

    Patrick E. Beans, manager of key entities, now has beneficial ownership of 45.7% of outstanding shares, reflecting his control over various trusts and LLCs.

  • Amendment to Prior Filing

    This is Amendment No. 4 to the Schedule 13D, updating ownership figures and confirming recent transactions.


Analysis

Entities associated with NRC Health's founder and Chairman, Michael D. Hays, executed significant sales of common stock, totaling over $5 million. This follows previous disclosures of reduced beneficial ownership and a registration to sell a large block of shares. The filing also confirms that Michael D. Hays' direct beneficial ownership (excluding disclaimed shares) fell below the 5% threshold as of March 23, 2026, indicating a continued reduction in his personal stake in the company. These sales represent a notable portion of the company's market capitalization and contribute to an overhang on the stock.

At the time of this filing, NRC was trading at $18.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $423.5M. The 52-week trading range was $11.01 to $22.79. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NRC - Latest Insights

NRC
Jun 12, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $18.79
Real-time Price: $18.79 info
Change: $0 (0%) info
Market Cap: $423.465M info
NRC
May 13, 2026, 4:09 PM EDT
Filing Type: 424B7
Importance Score:
9
Price at Filing: $18.52
Real-time Price: $18.79 info
Change: +$0.270 (+1%) info
Market Cap: $423.465M info
NRC
May 08, 2026, 9:44 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $18.69
Real-time Price: $18.79 info
Change: +$0.100 (+0.54%) info
Market Cap: $423.465M info
NRC
May 06, 2026, 11:51 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $18.23
Real-time Price: $18.79 info
Change: +$0.560 (+3%) info
Market Cap: $423.465M info
NRC
May 06, 2026, 11:42 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.29
Real-time Price: $18.79 info
Change: +$0.500 (+3%) info
Market Cap: $423.465M info
NRC
Apr 28, 2026, 5:19 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $16.84
Real-time Price: $18.79 info
Change: +$1.95 (+12%) info
Market Cap: $423.465M info
NRC
Apr 28, 2026, 5:16 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $16.84
Real-time Price: $18.79 info
Change: +$1.95 (+12%) info
Market Cap: $423.465M info
NRC
Apr 28, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.84
Real-time Price: $18.79 info
Change: +$1.95 (+12%) info
Market Cap: $423.465M info
NRC
Apr 28, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.84
Real-time Price: $18.79 info
Change: +$1.95 (+12%) info
Market Cap: $423.465M info
NRC
Apr 20, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.18
Real-time Price: $18.79 info
Change: +$0.610 (+3%) info
Market Cap: $423.465M info